The reported statements, read against the company's own industry.
What stands out
Valued far above the size of its business
Financials view
Market Capitalization
8.18BCNY
1.22B · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
451.13MCNY
67.09M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-11.59%
Updated Aug 21, 2026
Beta
1.04x
vs all stocks
Updated Aug 21, 2026
52-Week Change
83.49%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
8.18BCNY
1.22B · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
9.10BCNY
1.35B · vs all stocks (USD)
Updated Aug 21, 2026
Price to Sales (TTM)
18.49x
Updated Aug 21, 2026
Price to Book (MRQ)
6.46x
Updated Aug 21, 2026
Enterprise to Revenue
20.17x
Updated Aug 21, 2026
Gross Margin
36.62%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 31.7%.Updated Aug 21, 2026
Profit Margin
-11.59%
Updated Aug 21, 2026
Operating Margin
-24.15%
Updated Aug 21, 2026
Return on Assets (TTM)
-1.87%
Updated Aug 21, 2026
Return on Equity (TTM)
-5.70%
Updated Aug 21, 2026
Revenue (TTM)
451.13MCNY
67.09M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
3.97CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
-26.80%
Updated Aug 21, 2026
Gross Profit (TTM)
142.99MCNY
21.26M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
49.79MCNY
7.40M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-52.28MCNY
-7.78M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
-80.22%
Updated Aug 21, 2026
Operating Cash Flow (TTM)
-1.02MCNY
-151.77K · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
-75.57MCNY
-11.24M · vs all stocks (USD)
Updated Aug 21, 2026
Payout Ratio
0.00%
Updated Aug 21, 2026
Minority Interest (Equity)
16.13MCNYFY2025 · Dec 31, 2025
Revenue
474.50MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
330.60MCNYFY2025 · Dec 31, 2025
Gross Profit
143.90MCNYFY2025 · Dec 31, 2025
Operating Income
2.47MCNY
367.29K · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-81.30MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-4.74MCNYFY2025 · Dec 31, 2025
Net Income
-76.56MCNYFY2025 · Dec 31, 2025
EBIT
-74.89MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
49.79MCNYFY2025 · Dec 31, 2025
Research & Development
50.72MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
30.61MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.06MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
921.02KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
6.41MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.4600CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.4600CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
114.16MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
114.16MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-76.56MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
24.05MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-159.80MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-247.32MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
169.95MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-76.56MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
7.64MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-94.25MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
3.38MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-87.52MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-291.77MCNYFY2025 · Dec 31, 2025
Sale of Investments
333.22MCNYFY2025 · Dec 31, 2025
Other Investing Activity
1.07MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-45.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
127.87MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-181.87MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-6.24MCNYFY2025 · Dec 31, 2025
Other Financing Charges
17.99MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-42.25MCNYFY2025 · Dec 31, 2025
Shares Outstanding
113.06MSharesUpdated Aug 21, 2026
Float Shares
69.56MSharesUpdated Aug 21, 2026
% Held by Insiders
53.30%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
1.25%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
207.59MCNY
30.87M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
1.87CNYUpdated Aug 21, 2026
Total Debt (MRQ)
168.03MCNY
24.99M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.1324x
Updated Aug 21, 2026
Current Ratio (MRQ)
2.21x
Updated Aug 21, 2026
Book Value per Share (MRQ)
11.42CNYUpdated Aug 21, 2026
Total Assets
1.91BCNY
283.84M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.19BCNYFY2025 · Dec 31, 2025
Total Liabilities
623.30MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
720.43MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
68.62MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
554.68MCNYFY2025 · Dec 31, 2025
Cash
161.07MCNYFY2025 · Dec 31, 2025
Cash Equivalents
14.19MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
175.26MCNYFY2025 · Dec 31, 2025
Accounts Receivable
597.58MCNYFY2025 · Dec 31, 2025
Inventory
298.23MCNYFY2025 · Dec 31, 2025
Accounts Payable
189.09MCNYFY2025 · Dec 31, 2025
Short-term Debt
96.59MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
52.34MCNYFY2025 · Dec 31, 2025
Long-term Debt
51.66MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
6.98MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
113.06MCNYFY2025 · Dec 31, 2025
Retained Earnings
31.15MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.29BCNY
191.15M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
22.69MCNYFY2025 · Dec 31, 2025
52-Week Low
30.00CNYUpdated Aug 21, 2026
52-Week High
147.00CNYUpdated Aug 21, 2026
52-Week Change
83.49%
vs all stocks
Updated Aug 21, 2026
Beta
1.04x
vs all stocks
Updated Aug 21, 2026
50-Day MA
86.45CNYUpdated Aug 21, 2026
200-Day MA
79.72CNYUpdated Aug 21, 2026
Avg 10-Day Volume
3.54MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
4.13MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-0.2800CNYUpdated Aug 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 18.49Revenue Growth YoY: -0.27
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.82
Altman Z-Score 8.41: safe zoneNotable
Altman Z-Score: 8.41
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Scale
Market cap is $1.22B, above the global median of $1.15BNotable
Market cap (USD): 1,216,380,753.502Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.